ONCAlert | 2017 San Antonio Breast Cancer Symposium

Toxicities Associated With PI3K Inhibitors

Denise A. Yardley, MD
Published Online: 8:52 PM, Thu December 11, 2014
Denise A. Yardley, MD, from Sarah Cannon Research Institute, discusses toxicities associated with treatment with PI3K inhibitors for breast cancer.

<<< Go back to the SABCS conference page



Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.